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A B S T R A C T
Purpose: To investigate whether genetic variants in inﬂammation-related genes are associated with
increased risk of childhood-onset febrile seizures.
Method: Tagging single nucleotide polymorphisms (SNPs) from 19 inﬂammation-related candidate
genes were identiﬁed and genotyped on the Sequenom platform in a sample of Caucasian childhood-
onset febrile seizures cases (n = 98) compared to ethnicity, age and gender matched febrile controls
presenting without seizures (n = 123). Tests for allelic association were carried out using PLINK. SNPs
generating empirical P-values (P < 0.05) were analysed in an expanded Caucasian control sample
(n = 2692) from the 1958 Birth Cohort.
Results: Six SNPs generated empirical pointwise signiﬁcance values P < 0.05 in the febrile seizures case–
control analysis in the P2X7R (purinergic receptor P2X7), TLR4 (toll-like receptor 4), IL6R (interleukin 6
receptor) and PTGER3 (prostaglandin E receptor 3, subtype EP3) genes. The most signiﬁcant result was for
missense SNP rs208294 in P2X7R (P = 0.009); this novel association was supported in the expanded case–
control analysis using the 1958 Birth Cohort (pointwise P = 0.009, OR = 0.63, familywise P = 0.039).
Conclusion: Genetic variants in inﬂammation-related genes, speciﬁcally purinergic receptor P2X7, may
be involved in susceptibility to childhood-onset febrile seizures.
 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
Seizure
jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
Febrile seizures (FS) affect 2–5% children under 5 years of age and
are usually associated with a viral infection not directly affecting the
brain but producing a sudden rise in body temperature. An
association exists with hippocampal sclerosis (HS), an important
cause of temporal lobe epilepsy (TLE), although whether HS is a
cause or consequence of FS has been somewhat controversial.1* Corresponding author at: Department of Neurology, Royal Preston Hospital,
Preston PR2 9HT, UK. Tel.: +44 1772 522558.
E-mail addresses: hedley.emsley@manchester.ac.uk, h.emsley@liv.ac.uk
(Hedley C.A. Emsley).
http://dx.doi.org/10.1016/j.seizure.2014.03.006
1059-1311/ 2014 British Epilepsy Association. Published by Elsevier Ltd. All rights reEpidemiological and recent prospective analyses of prolonged FS
and febrile status epilepticus do suggest that such seizures can lead
to TLE.2 Furthermore, persisting memory impairments have now
been reported in children after prolonged FS.3
Substantial evidence implicates immune and inﬂammatory
processes in the aetiopathogenesis of FS and HS. Interleukin-1 (IL-
1) is a key pro-inﬂammatory cytokine and ‘endogenous pyrogen’.
IL-1 has a pivotal inﬂuence in the host response to infection and
production of fever. Cytokine genes including IL-1 are up-regulated
in experimental seizures4 and IL-1b enhances seizure activity,5,6
whilst the naturally occurring IL-1 receptor antagonist (IL-1Ra) has
been shown to be powerfully anticonvulsant.7 Thus, altered
regulation of either the production or biological effects of IL-1
may be a critical determinant of susceptibility to FS. It is possibleserved.
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fever and a tendency to develop FS. Clinical studies suggest plasma
and cerebrospinal ﬂuid (CSF) cytokine concentrations change in
FS,8,9 and that speciﬁc IL-1 gene polymorphisms may increase the
risk of FS.10
Innate immune responses may both combat infectious
organisms and drive pathological inﬂammation, with inﬂamma-
some complexes, including the NLRP-3 inﬂammasome, being a
central component of these processes via regulation of IL-1b and
IL-18.11 The purinergic P2X7 receptor (P2X7R), a plasma
membrane receptor for extracellular ATP, is involved in an
apparently inﬂammasome dependent non-classical pathway of
IL-1b maturation, also involving caspase-1 activation.12 TLR4 is
a toll-like receptor which recognises bacterial lipopolysaccha-
ride and is important in innate immune system activation, with
TLR4 signalling also linked to inﬂammasome activation.13 In
terms of genes relevant to thermoregulation and IL-1 pathways,
3 of the most pertinent and ‘inﬂammation sensitive’ are
cyclooxygenase-2 (COX-2) and membrane associated prosta-
glandin E2 synthase (mPGES-1), which are key PGE2 synthesis-
ing enzymes, whilst EP3 is a PGE2 receptor expressed within the
CNS.
In this study, we chose to conduct an exploratory association
study of SNPs from nineteen IL-1 and other inﬂammation-related
candidate genes described above in a sample of Caucasian
childhood-onset FS cases compared to ethnicity, age and gender
matched febrile controls presenting without seizures. SNPs
showing evidence for association were further investigated in
an expanded ethnically matched control sample from the Well-
come Trust Case Control Consortium 1958 Birth Cohort
(1958BC).14
2. Methods
Appropriate local research ethics committee and research
governance approvals were obtained for this study. We
undertook a prospective case–control association study of 157
FS cases and 163 ethnicity and age-matched febrile controls
presenting to Alder Hey Children’s Hospital, Liverpool between
April 2006 and July 2009, and to Booth Hall Hospital,
Manchester, or Manchester Royal Inﬁrmary between August
2007 and July 2009.Table 1
Summary of genes investigated.
Gene Gene Name 
CASP1 Caspase 1 
IL18 Interleukin 18 
IL1A Interleukin 1, beta proprotein 
IL1B Interleukin 1, alpha proprotein 
IL1R1 Interleukin 1 receptor, type I 
IL1R2 Interleukin 1 receptor, type II 
IL1RN Interleukin 1 receptor antagonist 
IL33 Interleukin 33 
IL6 Interleukin 6 
IL6R Interleukin 6 receptor 
NLRP3 NLR family, pyrin domain containing 3 
P2X7R Purinergic receptor P2X7 
PTGER3 Prostaglandin E receptor 3, subtype EP3 
PTGES Prostaglandin E synthase 
PTGS2 Prostaglandin-endoperoxide synthase 2 precursor 
TLR4 Toll-like receptor 4 
TNF Tumour necrosis factor alpha 
TNFRSF1A Tumour necrosis factor receptor 1 
TNFRSF1B Tumour necrosis factor receptor superfamily member 1B 
a Number of tagging SNPs for each gene (redundant SNPs for assay failure).2.1. Cases and controls
Inclusion criteria for cases and controls were childhood febrile
illness with peak recorded aural temperature >38 8C and written
informed consent from a parent or guardian. Cases were additionally
required to have had a seizure, classiﬁed as simple or complex,
sporadic or familial as described below. Exclusion criteria for cases
and controls were family history of epilepsy; history of neurological
disease; history of any condition with potential to cause brain
damage (e.g. birth injury); and non-Caucasian ethnic origin. In
addition cases were excluded if there was evident cause of acute
symptomatic seizure, either evident central nervous system (CNS)
infection or metabolic disturbance, whilst controls were also
excluded if there was evident CNS infection or metabolic distur-
bance. Cases with FS were initially compared to ethnicity, age and
gender matched febrile controls presenting without seizures, as the
optimal control sample. An expanded ethnically matched control
sample from the Wellcome Trust Case Control Consortium 1958
Birth Cohort14 was used for conﬁrmatory analysis.
2.2. Febrile seizure classiﬁcation
FS were classiﬁed as simple if all of the four following features
were present: generalised tonic–clonic seizure activity without
focal features, <15 min in duration, no recurrence within a 24 h
period, and spontaneous resolution. FS were classiﬁed as complex
if any of the following features were present: focal onset or focal
features during the seizure, prolonged duration (15 min or longer),
or recurrence within 24 h or within the same febrile illness.
2.3. Sample collection
Buccal swabs were collected from all participants, and DNA
extracted as described previously.15 DNA samples were assessed for
quality using a commercially available assay (DNA OK). Additional
ethnically matched unselected UK control data were obtained from
the 1958 Birth Cohort,14 genotyped on the Illumina 1.2M array.
2.4. Candidate gene and SNP selection
Nineteen genes were selected based on their putative role in the
inﬂammatory response (Table 1). Two hundred and seventy-eight
SNPs were identiﬁed across these genes (10 kb ﬂanking sequence)Position (hg19) Gene size (bp) tSNPsa
Chr11:104896237–104905857 9620 7 (2)
Chr11:112013976–112034840 20,864 6
Chr2:113531492–113542971 11,479 4 (1)
Chr2:113587337–113594356 7019 3
Chr2:102759246–102796334 37,088 17
Chr2:102608306–102644884 36,578 15 (5)
Chr2:113875470–113891593 16,123 11 (3)
Chr9:6215807–6257982 42,175 8 (1)
Chr7:22766798–22771620 4822 6 (1)
Chr1:154377669–154440188 62,519 12 (2)
Chr1:247579475–247612406 32,931 23
Chr12:121570678–121623858 53,180 35 (8)
Chr1:71318036–71513491 195,455 69 (11)
Chr9:132500612–132515344 14,732 8 (2)
Chr1:186640969–186649556 8587 6
Chr9:120466610–120479766 13,156 10
Chr6:31543350–31546112 2762 9
Chr12:6437923–6451261 13,338 5
Chr1:12227149–12267077 39,928 24 (2)
Table 2
Summary of association results.a
Chr SNP Position A1 F_A F_U OR (95% CI) EMP1 F_58C OR (95% CI) EMP1 EMP2 Gene
12 rs208294 121600253 T 0.32 0.45 0.58 (0.37–0.91) 0.009 0.43 0.63 (0.45–0.89) 0.009 0.039 P2X7R
9 rs5030717 120473834 G 0.09 0.14 0.63 (0.32–1.23) 0.020 ND ND ND ND TLR4
1 rs10752641b 154432042 G 0.21 0.30 0.64 (0.39–1.03) 0.033 0.22 0.94 (0.65–1.37) 0.762 0.999 IL6R
1 rs1409162 71368758 A 0.49 0.45 1.18 (0.78–1.78) 0.039 0.48 1.05 (0.78–1.42) 0.762 0.999 PTGER3
1 rs5702 71331430 A 0.20 0.26 0.71 (0.43–1.19) 0.040 0.24 0.78 (0.53–1.15) 0.210 0.698 PTGER3
12 rs1718134 121607891 A 0.49 0.45 1.17 (0.77–1.8) 0.046 ND ND ND ND P2X7R
a SNPs with pointwise (EMP1) P < 0.05 in febrile seizures case–control samples are shown, allelic association test. Chr, chromosome. Position (hg19). Frequency of allele 1
(A1) in affected cases (F_A), unaffected controls (F_U) or 1958 Birth Cohort and febrile seizures combined controls (F_58C). OR, odds ratio. CI, conﬁdence interval. EMP1,
pointwise empirical P value. EMP2, familywise empirical P value. ND, not determined.
b Proxy rs4240872 in 1958 Birth Cohort (r2 = 1, HapMap CEU, rel 22).
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pairwise r2  0.8, minor allele frequency (MAF)  0.05. Thirty-eight
redundant SNPs were included (r2 = 1) for SNPs tagging 7 SNPs.
2.5. SNP genotyping
SNP genotyping was carried out by Mass-extension assay
using the Sequenom (R) MassARRAY technology (Sequenom, San
Diego). The Iplex assay was followed according to manufac-
turer’s instructions (http://www.sequenom.com) using 25 ng of
DNA. Assay chips were read using the Bruker Biﬂex III Mass
Spectrometer system. Sequenom Genotype Analyser was used
to manually check genotypes and to assign alleles, when
possible. Data were exported from SpectroTYPER using Report
Generator.
2.6. Quality control
The resulting genotype data were subject to quality control
before statistical analysis. SNPs with assay failure or genotyping
success rate <70% (n = 47) or Hardy Weinberg Equilibrium (HWE)
in controls (P < 0.001) (n = 16) were excluded. Individuals with
<75% genotyping success rate were also excluded (n = 42 cases, 34
controls). SNPs were tested for differential missingness in cases vs
controls, and 14 SNPs ﬂagged with P < 0.01. Sixteen SNPs with a
MAF < 0.05 were ﬂagged, but remained in the analyses. For
redundant SNPs (r2 = 1) genotyped in case of assay failure, one SNP
was retained for analysis based on tests for HWE in controls,
differential missingness between cases and controls, and genotyp-
ing success rate.
Quality control of the 1958 Birth Cohort data was based on the
WTCCC recommended cut-offs; call-rate, heterozygosity, ancestry,
discordant gender information, and duplicated or related samples
for samples, and for SNPs; minor allele frequency, HWE,
missingness and tests for plate association.
2.7. Statistical analysis
Allelic case–control association tests were conducted in PLINK
v1.07 (PLINK, a tool set for whole-genome association and
population-based linkage analyses) (http://pngu.mgh.harvar-
d.edu/purcell/plink/).16 Empirical signiﬁcance levels were calcu-
lated using 10,000 permutations, generating pointwise (per SNP,
EMP1) and familywise (controls for the number of SNPs tested,
EMP2) signiﬁcance levels, whilst preserving the correlational
structure between SNPs. For SNPs generating pointwise empirical
P < 0.05 in the FS case–control analysis (unadjusted for multiple
comparisons), additional allelic association tests were carried out
in PLINK in the subset of cases with simple FS, and using an
expanded Caucasian control sample from the WTCCC 1958 Birth
Cohort.143. Results
3.1. Febrile seizures analysis
After genotyping and quality control, 98 FS cases (n = 78 simple
and n = 20 complex FS), 123 FS controls and 181 SNPs were
included in the analysis. Six SNPs generated empirical pointwise
signiﬁcance values P < 0.05 in the FS case-control analysis in the
P2X7R (purinergic receptor P2X7), TLR4 (toll-like receptor 4), IL6R
(interleukin 6 receptor) and PTGER3 (prostaglandin E receptor 3,
subtype EP3) genes (Table 2). The most signiﬁcant result was for
rs208294, a missense C>T SNP creating a histidine to tyrosine
(H155Y) change in exon 5 of P2X7R (transcript variant 1,
NM_002562) (empirical P = 0.009, OR = 0.58, 95% conﬁdence
interval [CI] 0.37–0.91). None of these 6 SNPs were ﬂagged for
case–control missingness P < 0.01. Analysis of the subset of 78
cases with simple FS generated similar empirical pointwise
signiﬁcance values P < 0.05 for the three SNPs in P2X7R
(rs208294), PTGER3 (rs1409162) and TLR4 (rs5030717), suggesting
that this subset of FS cases may be driving this association (data not
shown). However, no SNPs remained signiﬁcant (P < 0.05) after
correcting for the number of SNPs tested.
3.2. Results of expanded analysis using the 1958 Birth Cohort
For 4 of the 6 SNPs generating pointwise empirical P < 0.05 in
the FS case control analysis, further analyses were carried out in an
expanded Caucasian control sample using genotype data from the
WTCCC 1958 Birth Cohort (n = 2692).14 Three of the 6 SNPs
(rs208294, rs5702 and rs1409162) were directly genotyped by the
WTCCC on the Illumina 1.2M array, whilst rs10752641 is perfectly
correlated with genotyped SNP rs4240872 (r2 = 1, HapMap CEU, rel
22). No proxy (r2 = 1) was available for rs5030717 or rs1718134, so
these two SNPs were not analysed further. Ninety-eight FS cases
and 2815 combined FS and 1958BC controls were included in this
analysis.
The results for missense SNP rs208294 in P2X7R were supported
in the expanded case-control analysis (pointwise P = 0.009,
OR = 0.63, 95% CI 0.45–0.89) (Table 2). This association remained
signiﬁcant after controlling for the number of SNPs tested
(P = 0.039). SNP rs208294 shows low linkage disequilibrium with
surrounding SNPs in the P2X7R gene, including the two ﬂanking
SNPs genotyped in this study (r2 = 0.22 with both rs6489794 and
rs1186055, HapMap CEU rel 28). The results for the other three
SNPs were not supported in the expanded case–control analysis
using the 1958 Birth Cohort controls.
4. Discussion
In this study, we investigated whether genetic variants in
inﬂammation-related genes are associated with increased risk of
H.C.A. Emsley et al. / Seizure 23 (2014) 457–461460childhood-onset FS. We identify 6 SNPs in the P2X7R, TLR4, IL6R and
PTGER3 genes that show nominal association, the most signiﬁcant
result being seen with a missense SNP rs208294 in P2X7R, which is
conﬁrmed in an expanded case–control analysis.
The occurrence of FS in only a proportion of children with febrile
illness points to host factors being important determinants of FS, in
keeping with the concept of genetic susceptibility. The pyrogenic
response to an inﬂammatory stimulus results from a complex series
of interactions involving neural, endocrine and immune systems.17
Prostaglandins and cytokines involved in central and peripheral
mechanisms associated with fever might have a role in FS.
Conceivably, variations in genes relevant to activation of innate
immune mechanisms, the regulation of inﬂammation and thermo-
regulation, might inﬂuence susceptibility to FS.
Our study identiﬁed nominal association of six SNPs to FS in the
P2X7R, TLR4, IL6R and PTGER3 genes. The most signiﬁcant
association was to a missense C>T SNP creating a histidine to
tyrosine change (H155Y) in exon 5 of P2X7R (transcript variant 1),
with the C allele being the risk allele in FS cases. This association of
P2X7R rs208294 was supported in an expanded analysis including
additional control samples from the 1958 Birth Cohort. The P2X7R
gene encodes for a purinoceptor for ATP which functions as a
ligand-gated ion channel and is responsible for ATP-dependent
lysis of macrophages through the formation of membrane pores
permeable to large molecules. A recent study has reported that the
T allele of rs208294 confers enhanced P2X7R receptor function,
resulting in increased ATP and calcium uptake and increased IL-18
and IL-1b release from monocytes in patients with rheumatoid
arthritis.18 Previous associations of this gene have been also
reported in candidate gene studies including major depressive
disorder,19 graft-vs-host-disease20 and tuberculosis,21,22 although
no studies have reported signiﬁcant association of this SNP or gene
at a genomewide signiﬁcance level.23
There have been a number of previous IL-1 single nucleotide
polymorphism association studies in epileptic disorders. One
Human Genomic Epidemiology study and meta-analysis assessed
the association of the IL-1b promoter region IL-1b-511T SNP
(rs1799916) with TLE, TLE with HS, FS and other epileptic
disorders.24 This showed a modest association (OR 1.48; 95% CI
1.09–2.00, P = 0.01) between the IL-1b-511T SNP and TLE with HS.
A signiﬁcant association was reported between the IL-1b-511T
SNP and sporadic simple FS.25 Our study did not identify any
association to IL-1 genes in FS. Although we did not test the IL-1b-
511T SNP (rs1799916) directly, we did genotype rs16944, only
550 bp 50 of rs1799916 and in the same haplotype block, and this
SNP did not show any evidence of association.
Previous studies have variably distinguished simple and
complex FS. This is an important consideration because the
associations with chronic epilepsy syndromes, including TLE with
HS, differ between simple and complex FS. Contributory factors
may well differ between simple and complex FS. Our analysis of the
subset of cases with simple FS suggests that this subset may be
driving the associations identiﬁed, although sample numbers were
too small to provide conclusive evidence, or to examine the subset
of cases with complex FS.
It has been suggested that a ‘systems biology approach’ is needed
to investigate the intricate genome–proteome–metabolome inter-
action in unravelling FS susceptibility.17 We have conducted an
exploratory case control association study using a candidate gene
approach to investigate whether genetic variants in 19 inﬂamma-
tion-related genes are associated with increased risk of childhood-
onset FS. This is the most extensive study conducted to date in FS in
terms of number of inﬂammation-related genes investigated,
although we recognise that this study lacked power to detect
genetic variants of moderate effect. Notwithstanding this limitation,
our results suggest that coding variation in the P2X7R gene maycontribute to susceptibility to childhood FS. In order to replicate this
ﬁnding and to pursue further investigation of this complex area it is
likely that large multicentre studies involving thousands of cases
will be required, also including other ethnicities, and potentially
adopting a genome wide association study approach. The identiﬁ-
cation of relevant inﬂammatory mediators might open up new
therapeutic targets.
Conﬂict of interest statement
None declared.
Acknowledgements
The study was funded by a research grant awarded by Cerebra.
The study made use of data generated by the Wellcome Trust Case-
Control Consortium. A full list of the investigators who contributed
to the generation of these data is available from www.wtccc.org.uk.
References
1. Waruiru C, Appleton R. Febrile seizures: an update. Arch Dis Child
2004;89(8):751–6.
2. McClelland S, Dube´ CM, Yang J, Baram TZ. Epileptogenesis after prolonged
febrile seizures: mechanisms, biomarkers and therapeutic opportunities. Neu-
rosci Lett 2011;497(3):155–62.
3. Martinos MM, Yoong M, Patil S, Chin RF, Neville BG, Scott RC, et al. Recognition
memory is impaired in children after prolonged febrile seizures. Brain
2012;135(Pt 10):3153–64.
4. Jankowsky JL, Patterson PH. The role of cytokines and growth factors in seizures
and their sequelae. Prog Neurobiol 2001;63(2):125–49.
5. Patel HC, Ross FM, Heenan LE, Davies RE, Rothwell NJ, Allan SM. Neurodegen-
erative actions of interleukin-1 in the rat brain are mediated through increases in
seizure activity. J Neurosci Res 2006;83:385–91.
6. Balosso S, Maroso M, Sanchez-Alavez M, Ravizza T, Frasca A, Bartfai T, et al. A
novel non-transcriptional pathway mediates the proconvulsive effects of inter-
leukin-1beta. Brain 2008;131:3256–65.
7. Vezzani A, Moneta D, Conti M, Richichi C, Ravizza T, De Luigi A, et al. Powerful
anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and
astrocytic overexpression in mice. Proc Natl Acad Sci USA 2000;97(21):11534–9.
8. Haspolat S, Mihc¸i E, Cos¸ kun M, Gu¨mu¨slu¨ S, Ozben T, Yeg˘in O. Interleukin-1beta,
tumor necrosis factor-alpha, and nitrite levels in febrile seizures. J Child Neurol
2002;17(10):749–51.
9. Virta H, Hurme M, Helminen M. Increased plasma levels of pro- and anti-
inﬂammatory cytokines in patients with febrile seizures. Epilepsia
2002;43(8):920–3.
10. Wu ZQ, Sun L, Sun YH, Ren C, Jiang YH, Lv XL. Interleukin 1 beta -511 C/T gene
polymorphism and susceptibility to febrile seizures: a meta-analysis. Mol Biol
Rep 2012;39(5):5401–7.
11. Rathinam VA, Vanaja SK, Fitzgerald KA. Regulation of inﬂammasome signaling.
Nat Immunol 2012;13(4):333–42.
12. Qu Y, Franchi L, Nunez G, Dubyak GR. Nonclassical IL-1 beta secretion stimulated
by P2X7 receptors is dependent on inﬂammasome activation and correlated with
exosome release in murine macrophages. J Immunol 2007;179(3):1913–25.
13. Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity:
update on toll-like receptors. Nat Immunol 2010;11(5):373–84.
14. Wellcome Trust Case Control Consortium. Genome-wide association study of
14,000 cases of seven common diseases and 3000 shared controls. Nature
2007;447(7145):661–78.
15. Freeman B, Smith N, Curtis C, Huckett L, Mill J, Craig IW. DNA from buccal swabs
recruited by mail: evaluation of storage effects on long-term stability and
suitability for multiplex polymerase chain reaction genotyping. Behav Genet
2003;33(1):67–72.
16. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al.
PLINK: a tool set for whole-genome association and population-based linkage
analyses. Am J Hum Genet 2007;81:559–75.
17. Prasad AN, Seshia SS. Susceptibility to febrile seizures: more than just a faulty
thermostat!. Can J Neurol Sci 2009;36(3):277–9. Erratum in: Can J Neurol Sci
2009;36(4):A-23.
18. Portales-Cervantes L, Nin˜o-Moreno P, Salgado-Bustamante M, Garcı´a-Herna´n-
dez MH, Baranda-Candido L, Reynaga-Herna´ndez E, et al. The His155Tyr
(489C>T) single nucleotide polymorphism of P2RX7 gene confers an enhanced
function of P2X7 receptor in immune cells from patients with rheumatoid
arthritis. Cell Immunol 2012;276(1–2):168–75.
19. Lucae S, Salyakina D, Barden N, Harvey M, Gagne´ B, Labbe´ M, et al. P2RX7, a
gene coding for a purinergic ligand-gated ion channel, is associated with major
depressive disorder. Hum Mol Genet 2006;15(16):2438–45.
20. Lee KH, Park SS, Kim I, Kim JH, Ra EK, Yoon SS, et al. P2X7 receptor polymor-
phism and clinical outcomes in HLA-matched sibling allogeneic hematopoietic
stem cell transplantation. Haematologica 2007;92(5):651–7.
H.C.A. Emsley et al. / Seizure 23 (2014) 457–461 46121. Li CM, Campbell SJ, Kumararatne DS, Bellamy R, Ruwende C, McAdam KP, et al.
Association of a polymorphism in the P2X7 gene with tuberculosis in a
Gambian population. J Infect Dis 2002;186(10):1458–62.
22. Fernando SL, Saunders BM, Sluyter R, Skarratt KK, Goldberg H, Marks GB, et al. A
polymorphism in the P2X7 gene increases susceptibility to extrapulmonary
tuberculosis. Am J Respir Crit Care Med 2007;175(4):360–6.
23. Hindorff LA, MacArthur J (European Bioinformatics Institute), Morales J (Euro-
pean Bioinformatics Institute), Junkins HA, Hall PN, Klemm AK, et al. A catalogof published genome-wide association studies. Available at: www.genome.gov/
gwastudies [accessed 21.06.2013].
24. Kauffman MA, Moron DG, Consalvo D, Bello R, Kochen S. Association study
between interleukin 1 beta gene and epileptic disorders: a HuGe review and
meta-analysis. Genet Med 2008;10(2):83–8.
25. Kira R, Ishizaki Y, Torisu H, Sanefuji M, Takemoto M, Sakamoto K, et al. Genetic
susceptibility to febrile seizures: case–control association studies. Brain Dev
2010;32(1):57–63.
